All Sauce from Weekly Sauce:

Could a therapy used to treat chest pain ease the debilitating symptoms of long COVID? Yes, claims a small but promising study that found it helped ease fatigue, shortness of breath and other symptoms in people who can’t shake side effects that haunt them long after their original coronavirus infection. As many as 50% of…  read on >  read on >

Scientists who conducted the first gene editing in ticks say this line of research could lead to new ways to reduce tick-borne diseases in humans. Ticks can transmit a wide number of diseases to people — including Lyme disease, babesiosis and Rocky Mountain spotted fever — but genetic knowledge about ticks is currently limited. That’s…  read on >  read on >

Antibodies against SARS-CoV-2 grow more effective in the months after a person gets the Pfizer COVID vaccine, according to a new study. In sheer numbers, antibody levels did decline over the months after vaccination. However, the new findings showed that antibodies that remained became steadily stronger and more precisely targeted against the virus. That means…  read on >  read on >

Misinformation about COVID-19 abounds, and cancer patients who are currently receiving treatment are more likely to believe COVID lies than cancer survivors who’ve completed treatment and people who’ve never had cancer, a new study says. The findings are from a survey of nearly 900 U.S. adults about evenly divided into the three groups. “These findings…  read on >  read on >